CervoMed to Appoint William Elder as Chief Financial Officer
May 20, 2024 08:00 ET
|
CervoMed Inc.
BOSTON, May 20, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced the appointment...
Coca-Cola Consolidated Announces Commencement of Tender Offer to Purchase up to $2.0 Billion in Value of its Common Stock
May 20, 2024 08:00 ET
|
Coca-Cola Consolidated, Inc.
CHARLOTTE, N.C., May 20, 2024 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (NASDAQ: COKE) (the “Company”) announced today that it has commenced a modified “Dutch auction” tender offer to...
ABM Recognized as One of the Best Places to Work in Healthcare
May 20, 2024 08:00 ET
|
ABM Industries Incorporated
NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- ABM (NYSE: ABM), a leading provider of integrated facility services, infrastructure solutions, and parking management, has been recognized as one of the...
Discover the Newest Way to Create Punchy, Flavorful Beverages
May 20, 2024 08:00 ET
|
John I. Haas, Inc.
YAKIMA, Wash., May 20, 2024 (GLOBE NEWSWIRE) -- Today, John I. Haas, Inc. (HAAS®), renowned leader in the global hops industry, announces the release of their bold, new, flavor and aroma product:...
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
May 20, 2024 08:00 ET
|
Biora Therapeutics, Inc.
Four device performance studies demonstrate the NaviCap platform’s ability to deliver therapeutics directly to the colon under variable GI conditions.
authID to Hold Annual Meeting of Stockholders on June 26th
May 20, 2024 08:00 ET
|
authID Inc.
DENVER, May 20, 2024 (GLOBE NEWSWIRE) -- authID® [Nasdaq: AUID] a leading provider of innovative biometric identity verification and authentication solutions, today announced that its 2024 Annual...
Intercept Presents New Sub-Analyses of Phase 3 POISE Data Showcasing the Effect of OCA on Key Liver Biomarkers and Fibrosis in Patients with PBC at Digestive Disease Week® 2024
May 20, 2024 08:00 ET
|
Intercept Pharmaceuticals, Inc.
OCA normalizes levels of ALT and AST, liver biomarkers associated with poor clinical outcomes in a significantly higher proportion of patients after 12 months of treatment compared to placebo;...
“Breaking Points” Podcast Launches on Rumble
May 20, 2024 08:00 ET
|
Rumble, Inc.
Rumble ramps up its position as the premier platform for politics with the addition of the popular news commentary podcast. LONGBOAT KEY, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- Rumble, the...
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 20, 2024 08:00 ET
|
Standard BioTools Inc.
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Spinogenix Announces U.S. FDA Orphan Drug Designation Granted to SPG601 for the Treatment of Fragile X Syndrome
May 20, 2024 08:00 ET
|
Spinogenix, Inc.
SAN DIEGO, May 20, 2024 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients...